You just read:

Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology

News provided by

Inovio Pharmaceuticals, Inc.

Mar 14, 2011, 04:00 ET